Lymphoma Research

Current Clinical Trial Research Trials

ACCEPT

Info: ACCEPT Trial Registration
Type: Diffuse large B cell lymphoma
Centres: Oxford
Description: Phase I/II R-CHOP+acalabrutinib, front-line DLBCL

ACE-LY-110

Info: ACE-LY-110 Trial Registration
Type: Diffuse large B cell lymphoma
Centres: Oxford
Description: Phase I/II vistusertib + acalabrutinib in R/R DLBCL

INCA

Info: INCA Trial Registration
Type: Diffuse large B cell lymphoma
Centres: Oxford; Bucks
Description: DLBCL front line, co-morbid, PII

Maple

Info: Maple Trial Registration
Type: Diffuse large B cell lymphoma
Centres: Oxford, Bucks, Milton Keynes
Description: Tissue and data collection project in front line DLBCL

Unity-NHL

Info: Unity-NHL Trial Registration
Type: Diffuse large B cell lymphoma, follicular lymphoma, marginal zone lymphoma, SLL
Centres: Oxford
Description: Phase II umbrelisib + ublituximab +/- bendamustine in R/R NHL – DLBCL, FL, MZL, SLL

ADCT301-002

Info: ADCT301-002 Trial Registration
Type: Hodgkin and non Hodgkin lymphomas
Centres: Oxford
Description: Phase I using ADCT301 in R/R lymphoma

AVAIL-T

Info: AVAIL-T Trial Registration
Type: Relapsed/Refractory Peripheral T-cll Lymphoma (PTCL)
Centres: Oxford
Description: Avelumab in relapsed / refractory PTCL

ENRICH

Info: ENRICH Trial Registration
Type: Mantle Cell lymphoma
Centres: Oxford, Milton Keynes
Description: Ibrutinib and rituximab in front line elderly mantle cell lymphoma

BI-1206

Info: BI-1206 Trial Registration
Type: B-cell NHL, CLL and WM
Centres: Oxford
Description: Phase I/II using an anti-CD32b antibody +/- rituximab in R/R NHL and CLL

5F9003 trial

Info: 5F9003 trial Trial Registration
Type: Non-Hodgkin lymphoma
Centres: Oxford, Milton Keynes
Description: Phase I/II using an anti-CD47 antibody in combination with rituximab in R/R DLBCL and follicular lymphoma.

Fusion-NHL

Info: Fusion-NHL Trial Registration
Type: Non-Hodgkin lymphoma
Centres: Oxford
Description: Phase I/II involving durvalumab combination in R/R NHL

Javelin-NHL

Info: Javelin-NHL Trial Registration
Type: Non-Hodgkin lymphoma
Centres: Oxford
Description: Phase I/II involving avelumab combinations in R/R NHL

POLARIX

Info: POLARIX Trial Registration
Type: Diffuse Large B-Cell Lymphoma
Centres: Oxford
Description: RCHOP vs RCHP + polatuzumab vedotin in front line DLBCL

RIVA

Info: RIVA Trial Registration
Type: Relapsed/refractory B-cell non-Hodgkin Lymphoma
Centres: Oxford
Description: Phase II rituximab + varilumab in R/R NHL

RomiCar

Info: RomiCar Trial Registration
Type: Peripheral T Cell lymphoma
Centres: Oxford
Description: Phase I/II romidepsin and carfilzomib in R/R PTCL

TIDAL

Info: TIDAL Trial Registration
Type: Post transplant Lymphoproliferative disorder (PTLD)
Centres: Oxford
Description: Ibrutinib + Rituximab as first line treatment for PTLD

TIER

Info: TIER Trial Registration
Type: PCNSL
Centres: Oxford
Description: Phase I/II using thiotepa based chemotherapy in R/R PCNSL